Supply Chain

Abbott Laboratories will divest its eye care division to Johnson & Johnson for about $4.33 billion in cash, reported Reuters.

Jimmy Kimmel cracked a joke during the 2016 Emmy Awards about a topic few are smiling about: high drug prices.

Valeant Phramaceuticals is defending its drug discount program for two expensive heart drugs against reports that hospitals are not seeing any savings. The Canadian drugmaker said the program will cover more than 90 percent of the costs for U.S. hospitals,…

The Food and Drug Administration approved Bayer's hormonal contraceptive device Kyleena, reported Reuters.

Medeon Biodesign recently earned Food and Drug Administration approval for AbClose, a port site closure device.

Here are the six latest medical devices or drugs approved by the U.S. Food and Drug Administration.

Six Massachusetts hospitals are participating in a $3.6 million equity funding round to support Blue.Point, an Andover, Mass.-based healthcare startup company, according to the Boston Business Journal.

The Food and Drug Administration recently approved Yosprala, a pill that combines aspirin with the gastrointestinal drug omeprazole to prevent stomach ulcers in patients who take aspirin daily, according to Reuters.

Approval may be around the corner for Sarepta Therapeutics' Duchenne muscular dystrophy drug Eteplirsen since its biggest critic, Ronald Farkas, MD, PhD, left his role at the Food and Drug Administration, according to CNBC.

Dublin-based Medtronic received Food and Drug Administration approval for an expanded indication of its drug-coated balloon.